Open access
Open access
Powered by Google Translator Translator

All Posts

Just the Facts: What Drugs are Safe and Effective for COVID-19?

27 May, 2020 | 02:31h | UTC

Just the Facts: What drugs are safe and effective for COVID-19? – Canadian Journal of Emergency Medicine

Related Guidelines: NIH Coronavirus Disease 2019 (COVID-19) Treatment Guidelines – National Institutes of Health AND Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 Infection

“Apart from supportive care, there are no current effective therapeutics for COVID-19”

 


A Guide to COVID-19: A Global Pandemic Caused by the Novel Coronavirus SARS-CoV-2

27 May, 2020 | 02:22h | UTC

A Guide to COVID-19: A Global Pandemic Caused by the Novel Coronavirus SARS-CoV-2 – The FEBS Journal

 


Reasons to Worry Less About the Explosion of Preprints

27 May, 2020 | 02:24h | UTC

Reasons to Worry Less About the Explosion of Preprints – Absolutely Maybe Blog

 


Preprinting a Pandemic: The Role of Preprints in the COVID-19 Pandemic

27 May, 2020 | 02:25h | UTC

Preprinting a pandemic: the role of preprints in the COVID-19 pandemic – bioRxiv

 


Duration of Prone Position Sessions: A Prospective Cohort Study

27 May, 2020 | 02:20h | UTC

Duration of prone position sessions: a prospective cohort study – Annals of Intensive Care

 


Meta-analysis: Efficacy and Safety of Convalescent Plasma for Severe COVID-19

27 May, 2020 | 02:21h | UTC

Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis – Canadian Medical Association Journal

 


Lyme Borreliosis: Diagnosis and Management

27 May, 2020 | 02:19h | UTC

Lyme borreliosis: diagnosis and management – The BMJ (free for a limited period)

 


Short Review: Using Insulin to Treat Poorly Controlled Type 2 Diabetes in 2020

27 May, 2020 | 02:18h | UTC

Using Insulin to Treat Poorly Controlled Type 2 Diabetes in 2020 – JAMA (free for a limited period)

 


Randomized Trial: Antihypertensive Medication Reduction vs. Usual Care Among Older Adults Taking Multiple Antihypertensive Medications

27 May, 2020 | 02:16h | UTC

Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older: The OPTIMISE Randomized Clinical Trial – JAMA

Editorial: Deprescribing Antihypertensive Medications for Patients Aged 80 Years or Older: Is Doing Less Doing No Harm?

Commentary: Less is more? Deprescribing blood pressure lowering medications is safe in the short-term in older people with frailty and multiple long-term conditions – University of Oxford

 

Related Commentary on Twitter

 


Meta-Analysis: Vasopressin or Its Analogs are Not Associated with Reduced Mortality Compared to Catecholamines Alone in Patients with Septic Shock

27 May, 2020 | 02:13h | UTC

Clinical Efficiency of Vasopressin or Its Analogs in Comparison with Catecholamines Alone on Patients With Septic Shock: A Systematic Review and Meta-Analysis – Frontiers in Pharmacology

Related Review: Vasopressin and its analogues in shock states: a review – Annals of Intensive Care (free)

 


The Challenge of Implementing “Less is More” Medicine: A European Perspective

27 May, 2020 | 02:14h | UTC

The challenge of implementing Less is More medicine: A European perspective – European Journal of Internal Medicine

 


[Abstract Only] Study: Estimating the Lifetime Benefits of a Multi-drug Regimen for Heart Failure

27 May, 2020 | 02:41h | UTC

Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials – The Lancet (link to abstract – $ for full-text)

Commentary: Multi-drug regimen for heart failure could meaningfully extend patients’ lives – Brigham and Women’s Hospital

 

Related Commentary on Twitter

 


Study Shows Abnormalities in Placentas from COVID-19-positive Pregnant Women

26 May, 2020 | 10:00h | UTC

Placental Pathology in COVID-19 – American Journal of Clinical Pathology

Commentaries: Placentas from COVID-19-positive pregnant women show injury – Northwestern University AND Expert reaction to study looking at placentas from COVID19-positive pregnant women – Science Media Centre AND Covid-19 appears to attack placenta during pregnancy, study says – CNN AND Placenta Injury Observed in Pregnant Women Who Test Positive For Coronavirus – Forbes

 


SARS-CoV-2 in Pregnancy: A Comprehensive Summary of Current Guidelines

26 May, 2020 | 10:02h | UTC

SARS-CoV-2 in Pregnancy: A Comprehensive Summary of Current Guidelines – Journal of Clinical Medicine

Related: COVID-19 review of national clinical practice guidelines for key questions relating to the care of pregnant women and their babies

 


Review: COVID-19 and Cardiovascular Disease

26 May, 2020 | 10:05h | UTC

COVID-19 and Cardiovascular Disease – Circulation

Related Guidelines: COVID-19 rapid guideline: acute myocardial injury – National Institute for Health and Care Excellence AND ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic – European Society of Cardiology AND Management of Acute Myocardial Infarction During the COVID-19 Pandemic – Journal of the American Academy of Cardiology

 


Podcast: Evidence-Based Medicine for the Management of COVID-19 ARDS

26 May, 2020 | 09:57h | UTC

Critical Perspective: Evidence-Based Medicine for the Management of COVID-19 ARDS – American Thoracic Society

Related Perspective from the Author: In Defense of Evidence-Based Medicine for the Treatment of COVID-19 ARDS – Annals of the American Thoracic Society

 


Perspective: In Pandemic, Many Seeing Upsides to Telemedicine

26 May, 2020 | 09:52h | UTC

Part I: In pandemic, many seeing upsides to telemedicine – CIDRAP

Part II: COVID-19 reveals telehealth barriers, solutions – CIDRAP

 


Report: Smart Testing for COVID-19 Virus and Antibodies

26 May, 2020 | 09:55h | UTC

Smart testing for COVID-19 virus and antibodies – CIDRAP

News Release: In new report, CIDRAP at the University of Minnesota proposes smart and strategic approach to COVID-19 testing

See also: Reports 1 and 2

 


Study: Six Feet May Not Be Far Enough to Stop Coronavirus Transmission

26 May, 2020 | 09:48h | UTC

On coughing and airborne droplet transmission to humans – Physics of Fluids

Commentaries: Six feet not far enough to stop virus transmission in light winds – American Institute of Physics AND Expert reaction to paper studying mechanisms of coughing and airborne transmission of viruses – Science Media Centre AND Why 6 feet may not be enough social distance to avoid COVID-19 – Science News

 


Study: Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients

26 May, 2020 | 09:43h | UTC

Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients – the “Gabrin sign” – Journal of the American Academy of Dermatology

 


Perspective: “Here’s What Needs to Happen Before We Can All Get Vaccinated for COVID-19”

26 May, 2020 | 09:45h | UTC

Here’s what needs to happen before we can all get vaccinated for COVID-19 – CBC

 


Detailed Report into a Nosocomial Outbreak of COVID-19 in a South African Hospital

26 May, 2020 | 09:38h | UTC

Study tells ‘remarkable story’ about COVID-19’s deadly rampage through a South African hospital – Science

Original Study: Report into a nosocomial outbreak of coronavirus disease 2019 (COVID-19) at Netcare St. Augustine’s Hospital

 

Related Commentary on Twitter

https://twitter.com/EricTopol/status/1264922133722886144

 


Impact of COVID-19 on Oncology Clinical Trials

26 May, 2020 | 09:40h | UTC

Impact of COVID-19 on oncology clinical trials – Nature Reviews Drug Discovery

Commentary: More Than 200 International Cancer Trials Suspended Due to COVID-19 – Medscape (free registration required)

 


WHO Pauses Hydroxychloroquine Arm Of COVID-19 Clinical Trial Due to Safety Concerns

26 May, 2020 | 09:35h | UTC

WHO Pauses Hydroxychloroquine Arm Of COVID-19 Clinical Trial – After Lancet Study Finds Higher Mortality Rate Among Patients Getting The Drug – Health Policy Watch

See also: WHO halts hydroxychloroquine trial for coronavirus amid safety fears – The Guardian AND WHO Halts Hydroxychloroquine Trial Over Safety Concerns – NPR

 


Opinion: The ‘Just Stay Home’ Message Will Backfire

26 May, 2020 | 09:33h | UTC

The ‘Just Stay Home’ Message Will Backfire – The Atlantic

“We need less extreme and more nuanced recommendations for navigating life during the pandemic.”

 

Related Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.